Intervention

18F-TRX

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting1

Common conditions10

Lead sponsors shown1

Clinical trials

1 shown

Imaging of Solid Tumors Using 18F-TRXNCT06942104 · 2025-07-03

RECRUITING

Common conditions

Castration-Resistant Prostate Carcinoma1 Glioma, Malignant1 Locally Advanced Clear Cell Renal Cell Carcinoma1 Metastatic Clear Cell Renal Cell Carcinoma1 Metastatic Malignant Solid Neoplasm1 Solid Carcinoma1 Solid Tumor1 Stage III Renal Cell Cancer AJCC v81 Stage IV Renal Cell Cancer AJCC v81 Stage IVB Prostate Cancer AJCC v81

Leading sponsors

Rahul Aggarwal 1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.